California Court of Appeal

The trial court did not abuse its discretion in granting an order for class certification, however, the trial court erred where the class is overbroad to the extent it includes purchasers of the antibiotic Cipro who paid a flat copayment when they would have paid for a generic substitute under their health insurance.

Appellate Information

• Decided 08/05/2004
• Published 08/05/2004

Judges

• AARON, J.

Court

• California Court of Appeal

Counsel

• For Appellant:
  
• Luce, Forward, Hamilton & Scripps, Christopher J. Healey, Richard Spirra, Todd R. Kinnear, San Diego; Jones Day, Phillip A. Proger, William V. O'Reilly, Washington, DC, Craig E. Stewart, San Francisco; Bartlit, Beck, Herman, Palenchar, & Scott, Philip S. Beck, Fred H. Bartlit, Jr., and Michael J. Valaik, Chicago, IL, for Petitioner Bayer Corporation., Edelson & Rezzo and Joann F. Rezzo for Petitioners Barr Laboratories, Inc., The Rugby Group Inc., Watson Pharmaceuticals, Inc., and Hoechst Marion Roussel, Inc., Kirland & Ellis, Karen N. Walker and Edwin John U, Washington, DC, for Petitioner Barr Laboratories, Inc., Stinson, Morrison, Hecker, David E. Everson, Jr., Kay G. Noonan, Kansas City, MO, and Heather S. Woodson, Overland Park, KS, for Petitioners Hoechst Marion Roussel, Inc., and The Rugby Group, Inc., Lieff, Cabraser, Heimann & Bernstein, Joseph R. Saveri, Eric B. Fastiff, San Francisco; Zwerling, Schachter & Zwerling, Dan Drachler, Seattle, WA; Krause & Kalfayan, James C. Krause, Ralph B. Kalfayan, San Diego, and Agustin F. Lopez II for Real Parties in Interest.


• For Appellees:
  
• No appearance for Respondent.